{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:52:57Z","timestamp":1788205977800,"version":"build-2803163510"},"reference-count":69,"publisher":"American Psychiatric Association Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PS"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1176\/ps.49.9.1163","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T21:07:27Z","timestamp":1418850447000},"page":"1163-1172","source":"Crossref","is-referenced-by-count":156,"title":["Neuroleptic Malignant Syndrome: A Review"],"prefix":"10.1176","volume":"49","author":[{"given":"Anthony L.","family":"Pelonero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Levenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand K.","family":"Pandurangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R64991061","unstructured":"Delay J, Pichot P, Lemperiere T, et al: Un neuroleptique majeur non phenothiazine et non reserpine, l'haloperidol, dans le traitement des psychoses [Haloperidol, a nonphenothiazine, nonreserpine neuroleptic for the treatment of psychosis]. Annales Medico-Psychologiques 118:145-152, 1960"},{"key":"R64991063","doi-asserted-by":"crossref","unstructured":"Kurlan R, Hamill R, Shoullson I: Neuroleptic malignant syndrome. Clinical Neuropharmacology 7:109-120, 1984","DOI":"10.1097\/00002826-198406000-00001"},{"key":"R64991064","doi-asserted-by":"crossref","unstructured":"Levenson JL: Neuroleptic malignant syndrome. American Journal of Psychiatry 142:1137-1145, 1985","DOI":"10.1176\/ajp.142.10.1137"},{"key":"R64991065","doi-asserted-by":"crossref","unstructured":"Pearlman CA: Neuroleptic malignant syndrome: a review of the literature. Journal of Clinical Psychopharmacology 6:257-273, 1986","DOI":"10.1097\/00004714-198610000-00002"},{"key":"R64991066","doi-asserted-by":"crossref","unstructured":"Addonizio G, Susman VL, Roth SD: Neuroleptic malignant syndrome: review and analysis of 115 cases. Biological Psychiatry 22:1004-1020, 1987","DOI":"10.1016\/0006-3223(87)90010-2"},{"key":"R64991067","doi-asserted-by":"crossref","unstructured":"Shalev A, Hermesh H, Munitz H: Mortality from neuroleptic malignant syndrome. Journal of Clinical Psychiatry 50:18-25, 1989","DOI":"10.1016\/0006-3223(89)90275-8"},{"key":"R64991068","doi-asserted-by":"crossref","unstructured":"Gelenberg AJ, Bellinghausen B, Wojcik JD, et al: A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital. American Journal of Psychiatry 145:517-518, 1988","DOI":"10.1176\/ajp.145.4.517"},{"key":"R64991069","unstructured":"Keck PE, Sebastianelli J, Pope HG, et al: Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital. Journal of Clinical Psychiatry 50:352-355, 1989"},{"key":"R649910610","doi-asserted-by":"crossref","unstructured":"Pope HG, Cole JO, Choras PT, et al: Apparent neuroleptic malignant syndrome with clozapine and lithium. Journal of Nervous and Mental Disease 174:493-495, 1986","DOI":"10.1097\/00005053-198608000-00010"},{"key":"R649910611","doi-asserted-by":"crossref","unstructured":"Muller T, Becker T, Fritze J: Neuroleptic malignant syndrome after clozapine plus carbamazepine (letter). Lancet 2:1500, 1988","DOI":"10.1016\/S0140-6736(88)90986-5"},{"key":"R649910612","doi-asserted-by":"crossref","unstructured":"Sachdev P, Kruk J, Kneebone M, et al: Clozapine-induced neuroleptic malignant syndrome: review and report of new cases. Journal of Clinical Psychopharmacology 15:365-371, 1995","DOI":"10.1097\/00004714-199510000-00010"},{"key":"R649910613","doi-asserted-by":"crossref","unstructured":"Dave M: Two cases of risperidone-induced neuroleptic malignant syndrome (ltr). American Journal of Psychiatry 152:1233-1234, 1995","DOI":"10.1176\/ajp.152.8.1233b"},{"key":"R649910614","doi-asserted-by":"crossref","unstructured":"Singer S, Richards C, Boland RJ: Two cases of risperidone-induced neuroleptic malignant syndrome (ltr). American Journal of Psychiatry 152:1234, 1995","DOI":"10.1176\/ajp.152.8.1234a"},{"key":"R649910615","doi-asserted-by":"crossref","unstructured":"Friedman LS, Weinrauch LA, D'Elia JA: Metoclopramide-induced neuroleptic malignant syndrome. Archives of Internal Medicine 147:1495-1497, 1987","DOI":"10.1001\/archinte.147.8.1495"},{"key":"R649910616","doi-asserted-by":"crossref","unstructured":"Patterson JF: Neuroleptic malignant syndrome associated with metoclopramide. Southern Medical Journal 81:674-675, 1988","DOI":"10.1097\/00007611-198805000-00035"},{"key":"R649910617","doi-asserted-by":"crossref","unstructured":"Brower RD, Dreyer CF: Neuroleptic malignant syndrome in a child treated with metoclopramide for chemotherapy-related nausea (ltr). Journal of Child Neurology 4:230-232, 1989","DOI":"10.1177\/088307388900400320"},{"key":"R649910618","doi-asserted-by":"crossref","unstructured":"Madakasira S: Amoxapine-induced neuroleptic malignant syndrome. Drug Intelligence and Clinical Pharmacy 23:50-51, 1989","DOI":"10.1177\/106002808902300111"},{"key":"R649910619","doi-asserted-by":"crossref","unstructured":"Taylor NE, Schwartz HI: Neuroleptic malignant syndrome following amoxapine overdose. Journal of Nervous and Mental Disease 176:249-251, 1988","DOI":"10.1097\/00005053-198804000-00010"},{"key":"R649910620","doi-asserted-by":"crossref","unstructured":"Friedman JH, Feinberg SS, Feldman RG: A neuroleptic malignant-like syndrome due to levodopa therapy withdrawal. JAMA 254:2792-2795, 1985","DOI":"10.1001\/jama.254.19.2792"},{"key":"R649910621","doi-asserted-by":"crossref","unstructured":"Gibb WRG: Neuroleptic malignant syndrome in striatonigral degeneration. British Journal of Psychiatry 153:254-255, 1988","DOI":"10.1192\/bjp.153.2.254"},{"key":"R649910622","doi-asserted-by":"crossref","unstructured":"Kontaxakis V, Stefanis C, Markidis M, et al: Neuroleptic malignant syndrome in a patient with Wilson's disease (ltr). Journal of Neurology, Neurosurgery, and Psychiatry 51:1001-1002, 1988","DOI":"10.1136\/jnnp.51.7.1001"},{"key":"R649910623","doi-asserted-by":"crossref","unstructured":"Itoh H, Ohtsuka N, Ogita K, et al: Malignant neuroleptic syndrome: its present status in Japan and clinical problems. Folia Psychiatrica et Neurologica Japonica 31:565-576, 1977","DOI":"10.1111\/j.1440-1819.1977.tb00127.x"},{"key":"R649910624","unstructured":"Harsch HH: Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases. Journal of Clinical Psychiatry 48:328-333, 1987"},{"key":"R649910625","doi-asserted-by":"crossref","unstructured":"Keck PE, Pope HG, Cohen BM, et al: Risk factors for neuroleptic malignant syndrome. Archives of General Psychiatry 46:914-918, 1989","DOI":"10.1001\/archpsyc.1989.01810100056011"},{"key":"R649910626","doi-asserted-by":"crossref","unstructured":"Treloar AJ, Crook MA, Tuff P, et al: Iron status, movement disorders, and acute phase response in elderly psychotic patients. Journal of Neurology, Neurosurgery, and Psychiatry 57:208-210, 1994","DOI":"10.1136\/jnnp.57.2.208"},{"key":"R649910627","doi-asserted-by":"crossref","unstructured":"Otani K, Horiuchi M, Kondo T, et al: Is the predisposition to neuroleptic malignant syndrome genetically transmitted? British Journal of Psychiatry 158:850-853, 1991","DOI":"10.1192\/bjp.158.6.850"},{"key":"R649910628","doi-asserted-by":"crossref","unstructured":"Burch EA, Montoya J: Neuroleptic malignant syndrome in an AIDS patient (ltr). Journal of Clinical Psychopharmacology 9:228-229, 1989","DOI":"10.1097\/00004714-198906000-00022"},{"key":"R649910629","doi-asserted-by":"crossref","unstructured":"Addonizio G, Susman VL, Roth SD: Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry 143:1587-1590, 1986","DOI":"10.1176\/ajp.143.12.1587"},{"key":"R649910630","doi-asserted-by":"crossref","unstructured":"Roth SD, Addonizio G, Susman VL: Diagnosing and treating neuroleptic malignant syndrome (ltr). American Journal of Psychiatry 143:673, 1986","DOI":"10.1176\/ajp.143.5.673"},{"key":"R649910631","doi-asserted-by":"crossref","unstructured":"Pope HG, Keck PE Jr, McElroy SL: Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry 143:1227-1233, 1986","DOI":"10.1176\/ajp.143.10.1227"},{"key":"R649910632","doi-asserted-by":"crossref","unstructured":"VanPutten T, Beckson M, Marder SR: The neuroleptic malignant syndrome manifested as a prolonged confusional state (ltr). Journal of Clinical Psychopharmacology 8:229-230, 1988","DOI":"10.1097\/00004714-198806000-00026"},{"key":"R649910633","doi-asserted-by":"crossref","unstructured":"Clarke CE, Shand D, Yuill GM, et al: Clinical spectrum of neuroleptic malignant syndrome (ltr). Lancet 2:969-970, 1988","DOI":"10.1016\/S0140-6736(88)92643-8"},{"key":"R649910634","doi-asserted-by":"crossref","unstructured":"McCarthy A, Bourke S, Fahy J, et al: Fatal recurrence of neuroleptic malignant syndrome. British Journal of Psychiatry 152:558-559, 1988","DOI":"10.1192\/bjp.152.4.558"},{"key":"R649910635","doi-asserted-by":"crossref","unstructured":"Levinson DF, Simpson GM: Neuroleptic-induced extrapyramidal symptoms with fever: heterogeneity of the \"neuroleptic malignant syndrome.\" Archives of General Psychiatry 43:839-848, 1986","DOI":"10.1001\/archpsyc.1986.01800090025005"},{"key":"R649910636","doi-asserted-by":"crossref","unstructured":"Mann SC, Caroff SN, Bleier HR, et al: Lethal catatonia. American Journal of Psychiatry 143:1374-1381, 1986","DOI":"10.1176\/ajp.143.11.1374"},{"key":"R649910637","doi-asserted-by":"crossref","unstructured":"Castillo E, Rubin RT, Holsboer-Trachsler E: Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. American Journal of Psychiatry 146:324-328, 1989","DOI":"10.1176\/ajp.146.3.324"},{"key":"R649910638","doi-asserted-by":"crossref","unstructured":"Levenson JL: Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome (ltr). American Journal of Psychiatry 146:1241, 1989","DOI":"10.1176\/ajp.146.9.1241"},{"key":"R649910639","doi-asserted-by":"crossref","unstructured":"Shalev A, Hermesh H, Munitz H: The role of external heat load in triggering the neuroleptic malignant syndrome. American Journal of Psychiatry 145:110-111, 1988","DOI":"10.1176\/ajp.145.1.110"},{"key":"R649910640","doi-asserted-by":"crossref","unstructured":"Stoudemire A, Luther JS: Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment. International Journal of Psychiatry in Medicine 14:57-63, 1984","DOI":"10.2190\/LXD2-JTXJ-3LPQ-9PDN"},{"key":"R649910641","unstructured":"Van Agtamael MA, van Harten PN: Malignant neuroleptic syndrome: complete anticoagulant treatment or not? Nederlands Tijdschrift voor Geneeskunde 136:1870-1872, 1992"},{"key":"R649910642","doi-asserted-by":"crossref","unstructured":"Johnson SB, Alvarez WA, Freinhar JP: Rhabdomyolysis in retrospect: are psychiatric patients predisposed to this little-known syndrome? International Journal of Psychiatry in Medicine 17:163-171, 1987","DOI":"10.2190\/PW4M-BQ2X-0FT2-J6ML"},{"key":"R649910643","doi-asserted-by":"crossref","unstructured":"Lee S, Merriam A, Kim TS, et al: Cerebellar degeneration in neuroleptic malignant syndrome: neuropathologic findings and review of the literature concerning heat-related nervous system injury. Journal of Neurology, Neurosurgery, and Psychiatry 52:387-391, 1989","DOI":"10.1136\/jnnp.52.3.387"},{"key":"R649910644","doi-asserted-by":"crossref","unstructured":"Rothke S, Bush D: Neuropsychological sequelae of neuroleptic malignant syndrome. Biological Psychiatry 21:838-841, 1986","DOI":"10.1016\/0006-3223(86)90249-0"},{"key":"R649910645","doi-asserted-by":"crossref","unstructured":"Konikoff F, Kuritzky A, Jerushalmi Y, et al: Neuroleptic malignant syndrome induced by single injection of haloperidol (ltr). British Medical Journal 289:1228-1229, 1984","DOI":"10.1136\/bmj.289.6453.1228-d"},{"key":"R649910646","doi-asserted-by":"crossref","unstructured":"Legras A, Hurel D, Dabrowski G, et al: Protracted neuroleptic malignant syndrome complicating long-acting neuroleptic administration. American Journal of Medicine 85:875-878, 1988","DOI":"10.1016\/0002-9343(88)90753-X"},{"key":"R649910647","doi-asserted-by":"crossref","unstructured":"Rosenberg MR, Green M: Neuroleptic malignant syndrome: review of response to therapy. Archives of Internal Medicine 149:1927-1931, 1989","DOI":"10.1001\/archinte.149.9.1927"},{"key":"R649910648","doi-asserted-by":"crossref","unstructured":"Rosebush P, Stewart T: A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry 146:717-725, 1989","DOI":"10.1176\/ajp.146.6.717"},{"key":"R649910649","doi-asserted-by":"crossref","unstructured":"Sakkas P, Davis JM, Hua J, et al: Pharmacotherapy of neuroleptic malignant syndrome. Psychiatric Annals 21:157-164, 1991","DOI":"10.3928\/0048-5713-19910301-08"},{"key":"R649910650","unstructured":"Addonizio G, Susman VL: ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. Journal of Clinical Psychiatry 48:102-105, 1987"},{"key":"R649910651","unstructured":"Scheftner WA, Shulman RB: Treatment choice in neuroleptic malignant syndrome. Convulsive Therapy 8:267-279, 1992"},{"key":"R649910652","unstructured":"Davis JM, Janicak PG, Sakkas P, et al: Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convulsive Therapy 7:111-120, 1991"},{"key":"R649910653","unstructured":"Gold R, Lenox RH: Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence. Journal of Clinical Psychiatry 56:476-483, 1995"},{"key":"R649910654","doi-asserted-by":"crossref","unstructured":"Pelonero AL, Levenson JL, Silverman JJ: Neuroleptic therapy following neuroleptic malignant syndrome. Psychosomatics 26:946-948, 1985","DOI":"10.1016\/S0033-3182(85)72761-2"},{"key":"R649910655","doi-asserted-by":"crossref","unstructured":"Wells AJ, Sommi RW, Crismon ML: Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review. Drug Intelligence and Clinical Pharmacy 22:475-480, 1988","DOI":"10.1177\/106002808802200606"},{"key":"R649910656","doi-asserted-by":"crossref","unstructured":"Susman VL, Addonizio G: Recurrence of neuroleptic malignant syndrome. Journal of Nervous and Mental Disease 176:234-241, 1988","DOI":"10.1097\/00005053-198804000-00007"},{"key":"R649910657","unstructured":"Rosebush PI, Stewart TD, Gelenberg AJ: Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. Journal of Clinical Psychiatry 50:295-298, 1989"},{"key":"R649910658","unstructured":"Levenson JL, Fisher JG: Long-term outcome after neuroleptic malignant syndrome. Journal of Clinical Psychiatry 49:154-156, 1988"},{"key":"R649910659","unstructured":"Pope HG, Aizley HG, Keck PE, et al: Neuroleptic malignant syndrome: long-term follow-up of 20 cases. Journal of Clinical Psychiatry 52:208-212, 1991"},{"key":"R649910660","unstructured":"Gelenberg AJ, Bellinghausen B, Wojcik JD, et al: Patients with neuroleptic malignant syndrome histories: what happens when they are rehospitalized? Journal of Clinical Psychiatry 50:178-180, 1989"},{"key":"R649910661","unstructured":"Fernando MLD, Manchanda R, Kirk C: Neuroleptic malignant syndrome: a preventative program. Journal of Psychiatry and Neuroscience 17:31-33, 1992"},{"key":"R649910663","doi-asserted-by":"crossref","unstructured":"Velamoor VR, Norman RM, Caroff SN, et al: Progression of symptoms in neuroleptic malignant syndrome. Journal of Nervous and Mental Disease 182:168-173, 1994","DOI":"10.1097\/00005053-199403000-00007"},{"key":"R649910664","doi-asserted-by":"crossref","unstructured":"Caroff S, Rosenberg H, Gerber JC: Neuroleptic malignant syndrome and malignant hyperthermia (ltr). Lancet 1:244, 1983","DOI":"10.1016\/S0140-6736(83)92620-X"},{"key":"R649910665","doi-asserted-by":"crossref","unstructured":"Downey GP, Caroff S, Beck S, et al: Neuroleptic malignant syndrome patient with unique ethical and physiologic features. American Journal of Medicine 77:338-340, 1984","DOI":"10.1016\/0002-9343(84)90716-2"},{"key":"R649910666","doi-asserted-by":"crossref","unstructured":"Tollefson G: A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia. Journal of Clinical Psychopharmacology 2:266-270, 1982","DOI":"10.1097\/00004714-198208000-00006"},{"key":"R649910667","doi-asserted-by":"crossref","unstructured":"Scarlett JD, Zimmerman R, Berkovic SF: Neuroleptic malignant syndrome. Australian and New Zealand Journal of Medicine 13:70-73, 1983","DOI":"10.1111\/j.1445-5994.1983.tb04554.x"},{"key":"R649910668","unstructured":"Bond WS: Detection and management of the neuroleptic malignant syndrome. Clinical Pharmacology 3:302-307, 1984"},{"key":"R649910669","doi-asserted-by":"crossref","unstructured":"Blair DT, Dauner A: Neuroleptic malignant syndrome: liability in nursing practice. Journal of Psychosocial Nursing and Mental Health Services 31:5-12, 1993","DOI":"10.3928\/0279-3695-19930201-06"},{"key":"R649910670","doi-asserted-by":"crossref","unstructured":"Lannas PA, Packar JV: A fatal case of neuroleptic malignant syndrome. Medicine, Science, and the Law 33:86-88, 1993","DOI":"10.1177\/002580249303300118"},{"key":"R649910671","doi-asserted-by":"crossref","unstructured":"Lazarus A: Should neuroleptic malignant syndrome be treated in a private psychiatric hospital or a general hospital? General Hospital Psychiatry 12:245-247, 1990","DOI":"10.1016\/0163-8343(90)90061-G"}],"container-title":["Psychiatric Services"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/ps.49.9.1163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T18:54:49Z","timestamp":1722365689000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ps.49.9.1163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1176\/ps.49.9.1163"],"URL":"https:\/\/doi.org\/10.1176\/ps.49.9.1163","relation":{},"ISSN":["1075-2730","1557-9700"],"issn-type":[{"value":"1075-2730","type":"print"},{"value":"1557-9700","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}